Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 5, 2003, Pages 751-757

  Serretti, Alessandro ^a   Artioli, Paola ^a   Zanardi, Raffaella ^a   Rossini, David ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Antidepressant treatment; Bipolar disorder; Clinical features; Mood; Switch

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; FLUVOXAMINE; LITHIUM CARBONATE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM;

ADULT; AGE DISTRIBUTION; ARTICLE; BIPOLAR DISORDER; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ETHNOLOGY; FEMALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MANIA; MOOD DISORDER; RANDOMIZATION; RETROSPECTIVE STUDY; SEX DIFFERENCE;

EID: 0042632871     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00104-0     Document Type: Article

References (53)

1. Akiskal H.S. External validating criteria for psychiatric diagnosis: their application in affective disorders. J. Clin. Psychiatry. 41:1980;6-15.
2. Altshuler L.L., Post R.M., Leverich G.S., Mikalauskas K., Rosoff A., Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am. J. Psychiatry. 152:1995;1130-1138.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Association, Washington, DC.
4. Angst J. Switch from depression to mania - a record study over decades between 1920 and 1982. Psychopathology. 18:1985;140-154.
5. Bellini L., Gatti F., Gasperini M., Smeraldi E. A comparison between delusional and non-delusional depressives. J. Affect. Disord. 25:1992;129-138.
6. Benedetti F., Barbini B., Campori E., Colombo C., Smeraldi E. Dopamine agonist amineptine prevents the antidepressant effect of sleep deprivation. Psychiatry Res. 65:1996;179-184.
7. Benedetti F., Barbini B., Colombo C., Campori E., Smeraldi E. Infradian mood fluctuations during a major depressive episode. J. Affect. Disord. 41:1996;81-87.
8. Benedetti F., Colombo C., Barbini B., Campori E., Smeraldi E. Ongoing lithium treatment prevents relapse after total sleep deprivation. J. Clin. Psychopharmacol. 19:1999;240-245.
9. Benedetti F., Serretti A., Colombo C., Campori E., Barbini B., Di Bella D., Smeraldi E. Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am. J. Psychiatry. 156:1999;1450-1452.
10. Benedetti F., Campori E., Barbini B., Fulgosi M.C., Colombo C. Dopaminergic augmentation of sleep deprivation effects in bipolar depression. Psychiatry Res. 104:2001;239-246.
11. Boerlin H.L., Gitlin M., Zoellner L.A., Hammen C.L. Bipolar depression and antidepressant-induced mania - a naturalistic study. J. Clin. Psychiatry. 59:1998;374-379.
12. Bottlender R., Rudolf D., Strauss A., Moller H.J. Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients. J. Affect. Disord. 63:2001;79-83.
13. Bunney W.E. Jr., Goodwin F.K., Murphy D.L., House K.M., Gordon E.K. The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch. Gen. Psychiatry. 27:1972;304-309.
14. Cassidy F., Ahearn E.P., Carroll B.J. Symptom profile consistency in recurrent manic episodes. Compr. Psychiatry. 43:2002;179-181.
15. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 1988;8-14 Erlbaum, Hillsdale, NJ.
16. Colombo C., Benedetti F., Barbini B., Campori E., Smeraldi E. Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res. 86:1999;267-270.
17. D'Aquila P.S., Peana A.T., Tanda O., Serra G. Carbamazepine prevents imipramine-induced behavioural sensitization to the dopamine D(2)-like receptor agonist quinpirole. Eur. J. Pharmacol. 416:2001;107-111.
18. Dolberg O.T., Schreiber S., Grunhaus L. Transcranial magnetic stimulation-induced switch into mania: a report of two cases. Biol. Psychiatry. 49:2001;468-470.
19. Endicott J., Spitzer R. A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch. Gen. Psychiatry. 35:1978;837-844.
20. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0). 1995;Biometrics Research Department, New York State Psychiatric Institute, New York.
21. Gatti F., Bellini L., Gasperini M., Perez J., Zanardi R., Smeraldi E. Fluvoxamine alone in the treatment of delusional depression. Am. J. Psychiatry. 153:1996;414-416.
22. Ghaemi S.N. New treatments for bipolar disorder: the role of atypical neuroleptic agents. J. Clin. Psychiatry. 61(Suppl. 14):2000;33-42.
23. Goodwin F., Jamison K. Manic-Depressive Illness. 1990;Oxford Univ. Press, New York.
24. Goodwin F.K., Murphy D.L., Dunner D.L., Bunney W.E. Jr. Lithium response in unipolar versus bipolar depression. Am. J. Psychiatry. 129:1972;44-47.
25. Henry C., Sorbara F., Lacoste J., Gindre C., Leboyer M. Antidepressant-induced mania in bipolar patients: identification of risk factors. J. Clin. Psychiatry. 62:2001;249-255.
26. Keller M.B., Lavori P.W., Friedman B., Nielsen E., Endicott J., McDonald-Scott P., Andreasen N.C. The Longitudinal Interval Follow-Up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch. Gen. Psychiatry. 44:1987;540-548.
27. Koch S., Galloway M.P. MDMA induced dopamine release in vivo: role of endogenous serotonin. J. Neural. Transm. 104:1997;135-146.
28. Lattuada E., Serretti A., Cusin C., Gasperini M., Macciardi F., Smeraldi E. Symptomatologic analysis of psychotic and non-psychotic depression. J. Affect. Disord. 54:1999;183-187.
29. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., Weissman M.M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch. Gen. Psychiatry. 39:1982;879-883.
30. Lewis J.L., Winokur G. The induction of mania. A natural history study with controls. Archives of General Psychiatry. 39:1982;303-306.
31. Nolen W.A., Bloemkolk D. Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm. Neuropsychobiology. 42(Suppl. 1):2000;11-17.
32. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br. J. Psychiatry. 164:1994;549-550.
33. Perugi G., Micheli C., Akiskal H.S., Madaro D., Socci C., Quilici C., Musetti L. Polarity of the first episode, clinical characteristics, and course of manic depressive illness: a systematic retrospective investigation of 320 bipolar I patients. Compr. Psychiatry. 41:2000;13-18.
34. Post R.M. The psychobiology of dysphoric mania. Clin. Neuropharmacol. 15(Suppl. 1, Pt. A):1992;624A-625A.
35. Post R.M., Kotin J., Goodwin F.K. The effects of cocaine on depressed patients. Am. J. Psychiatry. 131:1974;511-517.
36. Prien R.F., Caffey E.M. Jr., Klett C.J. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch. Gen. Psychiatry. 28:1973;337-341.
37. Ramasubbu R. Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders. Acta Psychiatr. Scand. 104:2001;236-238. (discussion 238-239).
38. Serretti A., Lattuada E., Cusin C., Macciardi F., Smeraldi E. Analysis of depressive symptomatology in mood disorders. Depress. Anxiety. 8:1998;80-85.
39. Serretti A., Macciardi F., Cusin C., Lattuada E., Lilli R., Smeraldi E. Dopamine receptor D4 gene is associated with delusional symptomatology in mood disorders. Psychiatry Res. 80:1998;129-136.
40. Serretti A., Cavallini M.C., Macciardi F., Namia C., Franchini L., Souery D., Lipp O., Bauwens F., Smeraldi E., Mendlewicz J. Social adjustment and self-esteem in remitted patients with mood disorders. Eur. Psychiatry. 14:1999;137-142.
41. Serretti A., Lattuada E., Cusin C., Gasperini M., Smeraldi E. Clinical and demographical features of psychotic and nonpsychotic depression. Compr. Psychiatry. 40:1999;358-362.
42. Serretti A., Lattuada E., Lorenzi C., Lilli R., Smeraldi E. Dopamine receptor D2 ser/cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses. Mol. Psychiatry. 5:2000;270-274.
43. Serretti A., Lilli R., Lorenzi C., Lattuada E., Cusin C., Smeraldi E. Tryptophan hydroxylase gene and major psychoses. Psychiatr. Res. 103:2001;79-86.
44. Serretti A., Lilli R., Lorenzi C., Lattuada E., Smeraldi E. DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2,011 affected subjects. Am. J. Med. Genet. 105:2001;283-290.
45. Stoll A.L., Mayer P.V., Kolbrener M., Goldstein E., Suplit B., Lucier J., Cohen B.M., Tohen M. Antidepressant-associated mania: a controlled comparison with spontaneous mania. Am. J. Psychiatry. 151:1994;1642-1645.
46. van Scheyen J.D., van Kammen D.P. Clomipramine-induced mania in unipolar depression. Arch. Gen. Psychiatry. 36:1979;560-565.
47. Wehr T.A., Goodwin F.K. Can antidepressants cause mania and worsen the course of affective illness? Am. J. Psychiatry. 144:1987;1403-1411.
48. Whitworth T.L., Herndon L.C., Quick M.W. Psychostimulants differentially regulate serotonin transporter expression in thalamocortical neurons. J. Neurosci. 22:2002;RC192.
49. Zanardi R., Artigas F., Franchini L., Sforzini L., Gasperini M., Smeraldi E., Perez J. How long should pindolol be associated with paroxetine to improve the antidepressant response? J. Clin. Psychopharmacol. 17:1997;446-450.
50. Zanardi R., Franchini L., Gasperini M., Lucca L., Smeraldi E., Perez J. Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study. J. Clin. Psychopharmacol. 18:1998;441-446.
51. Zanardi R., Benedetti F., DiBella D., Catalano M., Smeraldi E. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of serotonin transporter gene. J. Clin. Psychopharmacol. 20:2000;105-107.
52. Zanardi R., Franchini L., Serretti A., Perez J., Smeraldi E. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study. J. Clin. Psychiatry. 61:2000;26-29.
53. Zwicker A.P., Calil H.M. The effects of REM sleep deprivation on striatal dopamine receptor sites. Pharmacol. Biochem. Behav. 24:1986;809-812.